Blue Fin Capital’s Thermo Fisher Scientific TMO Stock Holding History

Blue Fin Capital’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$345K	Sell	702 -14	-2%	-$7.6K	0.06%	123
2025 Q4	$415K	Sell	716 -23	-3%	-$13K	0.06%	113
2025 Q3	$358K	Sell	739 -31	-4%	-$14.4K	0.06%	122
2025 Q2	$312K	Sell	770 -50	-6%	-$20.9K	0.05%	124
2025 Q1	$408K	Sell	820 -9	-1%	-$4.87K	0.08%	104
2024 Q4	$431K	Sell	829 -24	-3%	-$13.2K	0.08%	101
2024 Q3	$528K	Buy	853 +86	+11%	+$50.9K	0.1%	94
2024 Q2	$424K	Hold	767	–	–	0.08%	102
2024 Q1	$446K	Sell	767 -7	-0.9%	-$3.93K	0.1%	99
2023 Q4	$411K	Hold	774	–	–	0.11%	99
2023 Q3	$392K	Sell	774 -2	-0.3%	-$1.07K	0.11%	98
2023 Q2	$405K	Hold	776	–	–	0.12%	102
2023 Q1	$423K	Buy	776 +11	+1%	+$6.2K	0.14%	96
2022 Q4	$421K	Hold	765	–	–	0.15%	94
2022 Q3	$388K	Hold	765	–	–	0.15%	91
2022 Q2	$415K	Hold	765	–	–	0.15%	91
2022 Q1	$451K	Sell	765 -55	-7%	-$31.6K	0.13%	92
2021 Q4	$547K	Hold	820	–	–	0.15%	86
2021 Q3	$468K	Hold	820	–	–	0.14%	88
2021 Q2	$413K	Hold	820	–	–	0.13%	91
2021 Q1	$374K	Buy	+820	New	+$391K	0.13%	89

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Blue Fin Capital's TMO Position: Q1 2026 in Review

Blue Fin Capital reduced its Thermo Fisher Scientific (TMO) stake by 2% in Q1 2026, selling an estimated $7.6K and leaving 702 shares worth $345K. The position accounts for 0.06% of the portfolio, ranked #123.

Blue Fin Capital first reported a position in TMO in Q1 2021 and has held it in 21 quarters since. The position peaked at $547K in Q4 2021. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Blue Fin Capital held 702 shares of Thermo Fisher Scientific worth $345K as of Q1 2026.
Blue Fin Capital sold 14 Thermo Fisher Scientific shares in Q1 2026, an estimated $7.6K.
Thermo Fisher Scientific made up 0.06% of Blue Fin Capital's portfolio in Q1 2026, its #123 holding.
Blue Fin Capital first reported a position in Thermo Fisher Scientific in Q1 2021 and has held it in 21 quarters since.
Blue Fin Capital's Thermo Fisher Scientific position peaked at $547K in Q4 2021.
2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Blue Fin Capital's 13F filing for Q1 2026, filed 28 May 2026.